Adage Capital Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.6M | Sell |
1,529,474
-619,526
| -29% | -$22.5M | 0.09% | 211 |
|
|
2025
Q1 | $77.8M | Buy |
2,149,000
+965,919
| +82% | +$35M | 0.14% | 138 |
|
|
2024
Q4 | $49.8M | Sell |
1,183,081
-342,660
| -22% | -$14.4M | 0.09% | 222 |
|
|
2024
Q3 | $84.8M | Buy |
1,525,741
+400,741
| +36% | +$22.3M | 0.15% | 136 |
|
|
2024
Q2 | $46.2M | Buy |
1,125,000
+975,000
| +650% | +$40.1M | 0.09% | 231 |
|
|
2024
Q1 | $7M | Sell |
150,000
-875,000
| -85% | -$40.9M | 0.01% | 658 |
|
|
2023
Q4 | $49M | Buy |
1,025,000
+935,000
| +1,039% | +$44.7M | 0.1% | 213 |
|
|
2023
Q3 | $3.21M | Sell |
90,000
-17,600
| -16% | -$627K | 0.01% | 710 |
|
|
2023
Q2 | $4.96M | Sell |
107,600
-14,400
| -12% | -$664K | 0.01% | 669 |
|
|
2023
Q1 | $4.89M | Sell |
122,000
-18,000
| -13% | -$722K | 0.01% | 709 |
|
|
2022
Q4 | $6.49M | Sell |
140,000
-15,062
| -10% | -$698K | 0.02% | 719 |
|
|
2022
Q3 | $6.42M | Sell |
155,062
-524,938
| -77% | -$21.7M | 0.02% | 745 |
|
|
2022
Q2 | $40.6M | Sell |
680,000
-20,000
| -3% | -$1.19M | 0.09% | 233 |
|
|
2022
Q1 | $50.8M | Hold |
700,000
| – | – | 0.1% | 210 |
|
|
2021
Q4 | $58.9M | Buy |
700,000
+80,000
| +13% | +$6.73M | 0.11% | 192 |
|
|
2021
Q3 | $55.9M | Buy |
620,000
+360,000
| +138% | +$32.5M | 0.11% | 197 |
|
|
2021
Q2 | $24.8M | Buy |
260,000
+75,000
| +41% | +$7.15M | 0.05% | 385 |
|
|
2021
Q1 | $21.1M | Buy |
185,000
+19,500
| +12% | +$2.22M | 0.04% | 433 |
|
|
2020
Q4 | $22.9M | Buy |
+165,500
| New | +$22.9M | 0.05% | 387 |
|
|
2018
Q4 | – | Sell |
-44,476
| Closed | -$3.4M | – | 745 |
|
|
2018
Q3 | $3.4M | Sell |
44,476
-283,024
| -86% | -$21.6M | 0.01% | 659 |
|
|
2018
Q2 | $25.2M | Sell |
327,500
-161,703
| -33% | -$12.4M | 0.06% | 353 |
|
|
2018
Q1 | $24.9M | Buy |
489,203
+381,703
| +355% | +$19.5M | 0.06% | 348 |
|
|
2017
Q4 | $4.99M | Sell |
107,500
-81,000
| -43% | -$3.76M | 0.01% | 626 |
|
|
2017
Q3 | $10M | Sell |
188,500
-279,000
| -60% | -$14.9M | 0.02% | 559 |
|
|
2017
Q2 | $29M | Buy |
467,500
+327,000
| +233% | +$20.3M | 0.07% | 339 |
|
|
2017
Q1 | $9.52M | Sell |
140,500
-488,000
| -78% | -$33.1M | 0.02% | 546 |
|
|
2016
Q4 | $44.2M | Sell |
628,500
-50,000
| -7% | -$3.52M | 0.12% | 220 |
|
|
2016
Q3 | $48.1M | Buy |
678,500
+40,000
| +6% | +$2.84M | 0.13% | 214 |
|
|
2016
Q2 | $31.2M | Buy |
638,500
+155,000
| +32% | +$7.58M | 0.09% | 276 |
|
|
2016
Q1 | $30.6M | Buy |
483,500
+150,000
| +45% | +$9.5M | 0.08% | 271 |
|
|
2015
Q4 | $37.4M | Sell |
333,500
-105,000
| -24% | -$11.8M | 0.1% | 245 |
|
|
2015
Q3 | $42.2M | Sell |
438,500
-186,500
| -30% | -$18M | 0.12% | 227 |
|
|
2015
Q2 | $64M | Sell |
625,000
-325,000
| -34% | -$33.3M | 0.16% | 178 |
|
|
2015
Q1 | $59M | Sell |
950,000
-116,826
| -11% | -$7.25M | 0.14% | 199 |
|
|
2014
Q4 | $46.8M | Buy |
1,066,826
+16,826
| +2% | +$738K | 0.11% | 245 |
|
|
2014
Q3 | $59.4M | Sell |
1,050,000
-706,968
| -40% | -$40M | 0.15% | 189 |
|
|
2014
Q2 | $78.9M | Sell |
1,756,968
-83,815
| -5% | -$3.76M | 0.2% | 141 |
|
|
2014
Q1 | $90M | Buy |
+1,840,783
| New | +$90M | 0.25% | 124 |
|